Human CD8 alpha expression in NK cells but not cytotoxic T cells of transgenic mice.
In our previous work, DNase hypersensitivity mapping was used to identify an enhancer within the human CD8 alpha (hCD8 alpha) gene which allowed T cell-specific expression of a reporter construct in transiently transfected cell lines. To study the role of this intronic enhancer in vivo, transgenic mice were made using human CD8 genomic constructs. We found that while a 14 kb wild-type human CD8 alpha (WThCD8) genomic construct did not lead to expression in mature peripheral CD8+ T cells, this transgene was consistently expressed in small populations of T cells and B cells, and in a subset of mouse NK cells. While murine CD8 is not normally expressed on resting NK cells, expression of the human CD8 transgene on mouse NK cells is appropriate since CD8 is expressed on a subset of human NK cells. Deletion of the intronic enhancer resulted in a complete loss of transgene expression in most lines and a loss of expression only in NK cells in one line. Our results indicate, firstly, that cis-acting sequences within the 14 kb genomic fragment are sufficient for NK cell-specific expression. In addition, our results suggest that the enhancer may have dual roles in regulation of transgene expression. It may enhance general expression of the transgene and may also be required for NK cell-specific expression.
Kieffer
L J
LJ
Section of Immunobiology, Yale University, New Haven, CT 06520, USA.
Bennett
J A
JA
Cunningham
A C
AC
Gladue
R P
RP
McNeish
J
J
Kavathas
P B
PB
Hanke
J H
JH
D000818:Animals; D016827:CD8 Antigens / Q000096:biosynthesis* / Q000235:genetics*; D015870:Gene Expression / Q000235:genetics*; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism*; D019076:Transgenes / Q000276:immunology
D016827:CD8 Antigens